Newsletter Subject

Fauci Was Hospitalized With Infection

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Aug 31, 2024 11:15 AM

Email Preheader Text

Weekly Review Saturday, August 31, 2024 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT CM

[MEDPAGE TODAY]( Weekly Review Saturday, August 31, 2024 [Fauci Was Hospitalized With Infection]( [What Do We Know About Kamala Harris' Medical History?]( [Wegovy Protects Against Deadly COVID Cases]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Elevating Treatment Selection and Sequencing in Multiple Myeloma: Personalized Decisions Through Lines of Therapy]( [Murdered Doc Suffered Prior Beating; Fake Plastic Surgeon; Doc Drugged Nanny]( [FDA Could Soon Limit Use of Only Drug for COVID Prevention]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Expert Epidemiologists on Everything COVID]( CME SPOTLIGHT [Exploring HER2 Targeting: Transforming Treatment for Metastatic and Locally Advanced HER2+ Cancers]( [An Unwelcome Souvenir From the Democratic National Convention: COVID]( [Experts: Don't Say 'Heartbeat' to Describe Ultrasound Findings in Early Pregnancy]( [MD Approves of Taylor Swift's Silence; Luteal Phase Explained; Choking and Alone?]( CME SPOTLIGHT [Optimizing Infusion Therapies to Advance Care in Metastatic HR+/HER2- and Triple-Negative Breast Cancer]( [Where Vance and Walz Stand on Major Healthcare Issues]( [The Global Fight Against Infection-Driven Cancers]( [Marked Cognitive Decline in Husbands After a Spouse's CVD Event?]( CME SPOTLIGHT [Updated Treatment Paradigms in HER2+ Breast Cancer]( [Stopping Beta-Blockers Did Not Go as Planned for Long-Time Users]( [Hormone Therapy May Slow Biological Aging in Women, Study Suggests]( [Clot Grabber IFU Recall; Free Cholesterol Tests at CVS; Naloxone for Cardiac Arrests]( CME SPOTLIGHT [Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care]( [COVID Vax Myocarditis Stays Mild With Good Prognosis Over a Year Later]( [Liveyon CEO Convicted in Stem Cell Scheme That Sickened Many]( [Olympic Chief Medical Officer on Athletes' GI Illness After Seine Events]( CME SPOTLIGHT [Optimizing Use of PARP Inhibitors in Early-Stage and Metastatic Breast Cancer Patients With DNA Damage Repair Pathway Mutations]( [Is Exercise an Effective Treatment for Prostate Cancer?]( [Your Patient Has Been Dealt a Hand With Four ACEs. What Now?]( ['Can Certainly Happen in Patients Who Are Not Surfers': What We Heard This Week]( CME SPOTLIGHT [Advancing the Integration of Biomarker Testing to Inform Treatment Selection in Advanced G/GEJ Cancers]( [How Should Unethical Legacies in Medical History Be Handled?]( [Neurologists Are the Latest Specialists to Exit Mission Health]( [Did the Dobbs Decision Impact Maternal Death Rates?]( CME SPOTLIGHT [Managing Adverse Events Associated With Novel Combination Therapies in RCC]( [Drops That Change Eye Color? Experts Sound the Alarm]( [Emerging Depression Tied to Earliest Alzheimer's Pathology]( [Inside Conservative Activist Leonard Leo's Long Campaign to Gut Planned Parenthood]( [Women's 30-Year Heart Risk Can Be Predicted by Just Three Factors]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2024-08-31&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.